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Abstract. In the last decade, imaging has been introduced as a supplementary method to the dissolution
tests, but a direct relationship of dissolution and imaging data has been almost completely overlooked.
The purpose of this study was to assess the feasibility of relating magnetic resonance imaging (MRI) and
dissolution data to elucidate dissolution profile features (i.e., kinetics, kinetics changes, and variability).
Commercial, hydroxypropylmethyl cellulose-based quetiapine fumarate controlled-release matrix tablets
were studied using the following two methods: (i) MRI inside the USP4 apparatus with subsequent
machine learning-based image segmentation and (ii) dissolution testing with piecewise dissolution model-
ing. Obtained data were analyzed together using statistical data processing methods, including multiple
linear regression. As a result, in this case, zeroth order release was found to be a consequence of internal
structure evolution (interplay between region’s areas—e.g., linear relationship between interface and
core), which eventually resulted in core disappearance. Dry core disappearance had an impact on (i)
changes in dissolution kinetics (from zeroth order to nonlinear) and (ii) an increase in variability of drug
dissolution results. It can be concluded that it is feasible to parameterize changes in micro/meso morphol-
ogy of hydrated, controlled release, swellable matrices using MRI to establish a causal relationship
between the changes in morphology and drug dissolution. Presented results open new perspectives in
practical application of combined MRI/dissolution to controlled-release drug products.
KEY WORDS: dissolution test; image analysis; machine learning; magnetic resonance imaging (MRI);
quetiapine fumarate.
INTRODUCTION
An understanding of drug release phenomena is crucial
for the interpretation of properties and behavior of dosage
form in vitro and in vivo. Despite imperfections, drug dissolu-
tion methods are among the most efficient and versatile tech-
niques for evaluation of pharmaceutical formulations. The
richness and diversity of dissolution equipment, as well as
experimental conditions, provide a wide range of their appli-
cations at the development stage of a medicinal product, in
quality control, post-approval changes, or as a surrogate for
in vivo studies (1). The power of these techniques stems from
their great sensitivity to variations in dosage form properties,
which are reflected in changes of dissolution profile. Unfortu-
nately, a similar, measurable effect may be caused by various
physicochemical factors, which significantly decreases speci-
ficity of dissolution tests (2, 3). Therefore, there is a need to
combine dissolution methods with other techniques to im-
prove their specificity and to further elucidate the mechanisms
of drug dissolution. In the recent decades, the application of
combined methods that integrate drug dissolution and imag-
ing techniques has increased noticeably (3–12).
One of the prominent imaging techniques is magnetic
resonance imaging (MRI). Microstructural properties of
controlled-release dosage forms as observed by MRI corre-
spond to molecular properties/behavior of water and its inter-
action with matrix components. During matrix hydration,
water concentration within the matrix as well as its interaction
with polymer molecules can result in the formation of specific
zones or layers (9, 13–16).
Despite the growing number of articles presenting drug
dissolution and imaging data, there is a lack of studies that
directly relate the evolution of internal structures occurring in
hydrating polymeric matrices with the drug release pro-
cess. An extensive literature review has shown that the
complicated relationship between dissolution and imaging
data is not fully understood. Some elements of such rela-
tionships that suggest the complicated interplay of struc-
tural and physicochemical factors during drug dissolution
are discussed by Tajarobi et al. (17).
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An equally important issue is the variability of drug dis-
solution in relation to the imaging data. Only a few papers in
the field, present results of the systematic image analysis;
however, the relationship between variability of drug dissolu-
tion results and measurements of internal structure parame-
ters has not been fully discussed (18, 19). It is also surprising
that there is a lack of publications presenting the results of MR
imaging of multiple independent samples.
The presented study aimed to:
& Present and discuss the results of the MRI measurements of
multiple independent samples of hydrated controlled-
release dosage form in relation to drug dissolution results.
& Introduce machine learning-based image analysis and quan-
tification of images of hydrated drug delivery systems, as
well as a short discussion on image analysis strategies.
MATERIALS AND METHODS
As a model dosage form, commercial controlled-release
tablets (Seroquel XR 400 mg, AstraZeneca) containing
quetiapine fumarate (QTP) and excipients, i.e., hypromellose
(HPMC), lactose monohydrate, microcrystalline cellulose, so-
dium citrate, and magnesium stearate, were used.
The dissolution study was carried out using the USP
apparatus 4 (DFZ 60, Erweka GmbH, Germany) equipped
with an USP 4 compliant piston pump (HKP 60, Erweka
GmbH, Germany) and 22.6-mm ID cells. The experiments
were performed in 1000 mL of distilled water circulating in
a closed loop. The flow rate was 10 mL/min; the tempera-
ture in the dissolution cell was maintained at 37±0.5°C. Five
milliliters; aliquots were taken every 0.5 h and the extracted
volume was replaced by a blank medium. The concentration
of dissolved QTP was determined by measuring UV absor-
bance at 289 nm (V-530 spectrophotometer Jasco, Japan).
Dissolution experiments were carried out in triplicate. Mean
values of dissolved QTP as well as their standard deviations
(SD) and relative standard deviations (RSD) were
calculated.
KinetDS software (20) was used for modeling the disso-
lution curve and establishing the possible time points, at which
dissolution kinetics switch. Piecewise mode was employed
with an approximation accuracy, i.e., a tolerance criterion, of
0.99 and nonlinear regression enabled. All available models in
the KinetDS library were employed in this analysis.
MRI was performed in a nonmagnetic flow-through cell
at 4.7 T research system (MARAN DRX, Oxford Instru-
ments, UK) using a flow-compensated spin-echo imaging
pulse sequence. Details of the experimental setup and proto-
col have been described previously (14). The images were
acquired during 6 h with a temporal resolution of 15 min.
MRI experiments were carried out for three different samples.
The image segmentation was performed using a Train-
able Weka Segmentation (TWS) plug-in module (http://fiji.sc/
Trainable_Weka_Segmentation), part of the public domain
software, Fiji distribution (21) of ImageJ v. 1.44 (National
Institutes of Health, http://rsb.info.nih.gov/ij/). The TWS relies
on algorithms included in Waikato Environment for Knowl-
edge Analysis (WEKA) data mining and machine learning
toolkit. Briefly, three separate regions in the matrix were
assumed and they were segmented using methods based on
image intensity and texture. Central sagittal images (Fig. 1a)
of each hydrated tablet obtained at consecutive time points
were stacked. Based on previously acquired knowledge, three
regions inside the hydrated matrix plus region outside the
matrix, which contained mainly dissolution medium, were
assumed (14, 22). Representative samples of these regions
originating from different images in the stack were manually
selected for classifier training purposes (an example is pre-
sented in Fig. 1b).
All available training features (filters) were applied to the
original image. The Fast Random Forest algorithm supported
by WEKA was used as a classifier. The classifier was trained
iteratively and finally was applied to the stacks to obtain
continuous segmented regions—an example is presented in
Fig. 1c, d. Figure 1e–h shows probability maps of the segment-
ed regions. On the basis of segmentation results, areas of dry
core, interface, and gel-like regions were obtained. Mean
values of areas at each hydration time points as well as their
standard deviations (SD) and relative standard deviations
(RSD) were calculated.
Finally, multiple linear regression was carried out using R
statistical environment routine lm() (23). The independent
variables were MRI and subsequent image analysis results,
namely gel-like, interface, and core areas. The dependent
variable was the amount of drug dissolved at each specific
time point. A time variable was not introduced; instead, each
case represented a particular/individual time point. Missing
values of independent variables were filled by means of inter-
polation of the curves over the time domain using R statistical
environment pchip() routine of the Bsignal^ package. A
direct analysis of lm() and its summary() routine was per-
formed to establish the input variables’ importance based on
the t statistic and the corresponding p values computed for all
coefficients.
RESULTS
Figure 2 shows dissolution and MRI data analysis results.
The dissolution of the drug over the course of the experi-
ment was incomplete (Fig. 2a). At the sixth hour, about 21% of
QTP was released. The analysis of the dissolution data with
KinetDS software revealed a change in the kinetics of drug
release at the fourth hour. This time point was selected auto-
matically by the KinetDS software independent of the user.
Piecewise mode of KinetDS works internally with three points
assumed as a minimum of each of the Bpieces^ into which the
original curve is dissected. Thus, the resulting switch-point
should be interpreted as a range-covering point assessed by
KinetDS and three preceding time points. In our case, this
resulted in the range of 3.25–4.0 h. Dissolution in the time range
of 0 to 4 h conformed to zeroth order kinetics, whereas beyond
4 h, it changed to nonlinear. As it is presented in Fig. 3, the
dissolution rate was constant and strongly fitted a linear rela-
tionship (R2=0. 9915) between the dry core area and the inter-
face area evolution (up to 3.5 h of hydration/dissolution).
According to our earlier experience, three regions in the
structure of hydrated Seroquel XR matrix tablets in MRI
images were identified (14, 22)—the core in the center of the
matrix, the external gel-like layer, and the interface area
between them. The interface region could be also identified
as a swollen glassy zone. Figure 2b shows the average results
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of the evolution of each region by means of its area, obtained
from three MRI measurements of independent samples. The
change of the overall cross-section area of the tablets during
6 h of drug dissolution was limited, it ranged from 124.2±3.7 to
153.4±8.6 mm2. The area of the gel-like layer increased grad-
ually from 34.3±4.7 to 93.3±12.8 mm2. During the 4 h of the
experiment, the interface area increased gradually at the ex-
pense of the core, reaching a maximum (85.7±3.0 mm2) at
3.75 h. At this moment, the core disappeared completely and
afterwards the area of the interface started to decrease.
As a result, dissolution and imaging-based data sets were
obtained. Both studies were performed in the same hydrody-
namic conditions. Therefore, it was possible to relate the
results of both studies. In particular, the changes in the struc-
ture of the hydrated tablets corresponded to the drug dissolu-
tion profile. Multiple linear regression was carried out to
evaluate functional relationships between the MRI and the
dissolution results. After the input variable reduction, two
independent variables, i.e., the dry core and interface areas
were found to be related to the amount of dissolved drug. The
resulting relationship is presented in Eq. (1), and detailed
diagnostics of the linear model is presented in the Table I.
Q ¼ −0:38x−0:52yþ 44:32 ð1Þ
where Q is released amount of QTP [%], x is area of interface
region [mm2], and y is the area of the core [mm2].
The goodness of fit measures presented in Table I
demonstrated that Eq. (1) was a representative model of
relationship between amounts of QTP released and corre-
sponding areas of tablets’ regions/layers, i.e., interface and
core, derived from MR images.
The change in dissolution kinetics at approximately 3.75 h
coincided with an abrupt change in the relationship between
the gel-like area and the interface area (see Fig. 4). After a
gradual increase of both parameters up to 3.75 h, the gel-like
layer area began to increase while the interface area started to
decrease. This phenomenon was associated with core loss (see
Fig. 2). During the initial phase of tablet hydration, the gel
layer and interface expanded at the expense of the core. After
core loss the area of the gel expanded at the expense of the
interface zone.
At the beginning of the dissolution (t<4 h), the variability
of the dissolution results was very low—standard deviation
(SD) ranged between 0.1 and 0.3% (see Fig. 2). Nevertheless,
it was noticeable after the fourth hour dissolution became
more variable (SD ranged from 1.3 to 3%). MRI results
showed (Fig. 2b) that at 3.75 h, the dry core disappeared.
After this time, SD of the gel-like and the interface evo-
lution profiles increased. For evolution of the gel-like
layer, the average SD was 1.6 mm2 up to 3.75 h. It
increased from 1.1 mm2 at 3.7 h to 2.9 mm2 at 4 h and
increased to 10.5 mm2 at 6 h. The average SD between 4
and 6 h was 6.9 mm2. Correlation of absolute values of
the variation coefficients (%RSD) showed a strong linear
relationship (R2>0.9) between relative standard deviations
of QTP released and RSD values for particular/individual
interface areas (Fig. 5).
Fig. 1. Diagram of image analysis procedure. a Original image obtained at 2 h of hydration, b manual
selection of a region’s samples for training purposes (red—core, green—interface region, magenta—gel-like
layer, yellow—medium and holder). c Result of image segmentation together with manual selection, d final
result of segmentation. e–h Probability maps for dry core, interface region, gel-like layer, and region outside
the tablet (water and holder) respectively
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DISCUSSION
The first aspect of this study was image analysis strategies
for assessment of changes in the internal structure of hydrated
controlled-release matrix systems. So far, image analysis issues
have only been marginally discussed in the works concerning
the application of MRI. Nott (8) has proposed identification of
the boundary between gel and non-hydrated core by using a
contour intensity that was halfway between the highest and
the lowest intensities inside the hydrated matrix—it has been
established for the first image and has been consequently used
throughout the series. This analysis assumed two internal
matrix regions, namely the hydrated and unhydrated regions.
In contrast, image intensity analysis has been applied by
Kulinowski et al. to identify the existence of three regions in
the hydrated matrix (14). These regions arise from three
different modes in the image intensity histogram and exhibit
internal inhomogeneity. In the subsequent study by
Kulinowski et al., it has been demonstrated using micro-CT
that this intra-region inhomogeneity is caused by the presence
of air inside the hydrated part of the matrix (22). Therefore,
image intensity-based segmentation (i.e., thresholding) may
provide appearance of discontinuous regions as a result—the
segmented regions may also contain pixels from other regions.
For example, the core region segmented by thresholding
contained pixels from the interface region but lacked pixels
from the center of the core (14). Due to intra-region inhomo-
geneity and consequently to image intensity variations, it was
necessary to choose an image segmentation method that take
into consideration the texture of the region. To this end, in the
current study, a machine learning approach using TWS was
applied. It required only a selection of a representative
Fig. 2. a Dissolution profile of QTP (n=3). Error bars represent standard deviation. b
Temporal evolution of areas of individual regions inside the tablet during hydration, derived
from MR images (n=3). Error bars represent standard deviation
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region’s samples (Fig. 1b). The method did not constrain the
number of regions, only initial assumptions regarding the
matrix structure under hydration were necessary.
The evolution of the internal structure in terms of layers in
Seroquel XR by MRI has been presented for the first time by
Kulinowski et al. in 2011 (14) and has been confirmed later by
Kulinowski et al. in 2015 usingMRIandmicro-CT (22). Zhang et al.
(18) have shown the evolution of thematrix in terms of gel and dry
core layer thickness for the commercial modified-release pharma-
ceutical product Lescol XL. In the subsequent study by Chen et al.
(24), dissolution profiles for Lescol XL have been related to the
results of 19F imaging of active substance. However, the dissolution
data has not been directly correlatedwith the results of 1H imaging,
which reflect the properties of water interacted with the matrix.
The dissolution tests allow simultaneous studies of sever-
al samples (usually six) at the same time, while the MRI can
be performed for only one sample at a time. Thus, it has been
a common practice to present imaging results for one hydra-
tion cycle of a single sample (3, 7, 14, 17–19, 25, 26). For
example, in the work by Zhang et al. (18), only one sample
was imaged, and the layer evolution data was plotted as the
mean of four layer thickness measurements, each taken in a
different direction. A similar approach is presented by
Punčochová et al. with regard to the MR images of tablets
containing Aprepitant solid dispersions (19). In this work, the
calculations of mean and SD of the front positions are based
on ten measurements performed on a single image. The only
exception was MRI results obtained by Nott (8) which con-
cerned six independent samples. Alas, the author has not
combined these results with those of dissolution test; there-
fore, their usefulness in our discussion is limited.
The relation between image features and dissolution data
has been given very little attention in previous studies.Dissolution
and imaging data together, obtained using a non-pharmacopoeial
flow-through cell, have been presented by Tajarobi et al. (17)
where HPMC matrices with mannitol as the soluble model of
active substance have been tested. The results demonstrate that
almost the entire dose of mannitol is released by the time the core
of the HPMC/mannitol tablet had disappeared.
Therefore, presentation, analysis, and correlation of
image-based evolution of the matrix with dissolution test re-
sults were the next logical step. That was the rationale for the
present work: to find features relating both data sets. As
described in the Results section, piecewise analysis of the
dissolution profile by KinetDS resulted in a division of the
profile into two parts of different characteristics. The first part
showed zeroth order release, which was associated with the
existence of a dry core and was achieved by proper balance
between the swollen region and the dry core (see Fig. 3).
Therefore, the existence of a dry core was crucial for a con-
stant release rate. Disappearance of the dry core was accom-
panied by the reversal of the relationship between the gel-like
and interface layers (see Fig. 4), which in turn resulted in the
loss of zeroth order release kinetics. It was probably one of the
most valuable observations of the study because it explained
Fig. 3. Relationship between interface area and core area
Table I. Description of LinearModel RelatingAmount ofQTPReleased
with Areas of Interface and the Core Regions as Presented in Eq. (1)
Coefficient diagnostics
Variable Coefficient Standard
error
p value
Intercept 44.32 0.4896 <2·10−16
Area of interface region (x) −0.38 0.0063 <2·10−16
Area of the core region (y) −0.51 0.0049 <2·10−16
Overall equation diagnostics
Residual standard error 0.2132
Root mean squared error
(RMSE)
0.1994
R2 0.9989
Adjusted R2 0.9988
p value (df=21) <2.2·10−16
QTP quetiapine fumarate
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the subtle effects observed in dissolution profiles using supple-
mentary imaging.WithoutMRI, such changes in dissolution char-
acteristics could be omitted or misinterpreted as results of
analytical errors. Furthermore, the image analysis methods used
were highly independent of the user, thus largely reducing the risk
of misinterpreting the data as a consequence of user error or bias.
One of the first imaging-based approaches used to assess
dissolution variability has been performed earlier byDorożyński
et al. (26). It has been carried out on commercial diclofenac
modified-release formulations. It has been found that the com-
plexity of the external matrix boundary described by fractal
dimension could be one of the sources of dissolution variability.
The results of the current study demonstrated that anoth-
er possible source of variability in dissolution results could be
the internal structure of the hydrated tablet itself. Data
presented in Fig. 2 showed that at the fourth hour, the SD of
dissolution results increased with the disappearance of the dry
core. On the other hand, the absence of a rigid internal struc-
ture caused an increase in variability of the cross-section areas
of the gel-like and interface layers.
The variability of drug dissolution results may stem from
various sources, e.g., uniformity of dosage forms, dissolution
conditions, and equipment (27, 28). Variability in dissolution
profiles is crucial for CR dosage forms due to safety and efficacy
reasons. In the current work, for the first time, the sources of
variability in dissolution results were addressed and were asso-
ciated with changes of the internal structure of the dosage form
during in vitro hydration and dissolution processes.
In standard approaches to drug dissolution, the reasons
for a particular dissolution curve features remained unknown.
Fig. 4. Relationship between gel-like layer area and interface area reverses after 3.75 h
Fig. 5. Correlation between RSD values for interface region area and dissolution results
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In fact, they could be induced by various factors. In 2003,
Sawada et al. elucidated the impact of some of these factors
that could not otherwise be identified by in vitro dissolution
test (2). The results of the current study demonstrated that
properly designed imaging studies and image analysis as a
supplement to dissolution data can be useful. However, it
should be kept in mind that every case requires its own ded-
icated methodology. To be able to correlate imaging results
and dissolution test results, image analysis should reflect the
actual structure of the matrix. This structure as imaged in USP
4 apparatus should be confirmed using other imaging modal-
ities, e.g., other MRI sequences or micro-CT. Such knowledge
should be gained prior to the attempt to correlate dissolution
and imaging-based data.
CONCLUSIONS
The results of the study showed that parameterization of the
changes in micro/meso morphology of hydrated, controlled-
release swellable matrices as obtained by magnetic resonance
imaging could be directly related to dissolution results. Magnetic
resonance imaging inside the USP apparatus 4 in real dissolution
testing conditions with subsequent machine learning-based image
segmentation, drug release studies with subsequent piecewise
dissolution profile modeling, and statistical data processing in-
cluding multiple linear regression were used to accomplish this
task. A causal relationship between matrix morphology changes
and drug dissolution was revealed.Moreover, anMRI performed
during dissolution testing allowed identification of potential
sources of dissolution variability.
In this particular case, dry core disappearance had an
impact on:
& Change in dissolution kinetics (from zeroth order to
unknown).
& Variability of in vitro drug dissolution—the increase in dis-
solution variability in vitro coincided with dry core
disappearance.
Presented results open new perspectives in practical ap-
plication of combined MRI/dissolution to controlled-release
drug products.
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